Jiwon Kim1, Hyojin Seong1,2, Kang Ju Son3, Eun Jee Chung4. 1. Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, #100 Ilsan-ro, Ilsandong-gu, Gyeonggi-do, 410-719, Goyang, Korea. 2. Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea. 3. Department of Research and Analysis, National Health Insurance Service Ilsan Hospital, Goyang, Korea. 4. Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, #100 Ilsan-ro, Ilsandong-gu, Gyeonggi-do, 410-719, Goyang, Korea. eunjee95@nhimc.or.kr.
Abstract
PURPOSE: To determine the age- and sex-specific annual incidence rates of patients treated for VTDR and the factors associated with increased treatment rates in patients with type 2 diabetes mellitus (T2DM) in South Korea. METHODS: This was a nationwide, retrospective, 12-year, population-based study. Patients aged over 30 years who were diagnosed with T2DM between 2006 and 2017 were included in this study. We evaluated the national health claims data acquired from the Korean National Health Insurance Service database. Main outcome measures were the annual incidence rates of patients treated for VTDR and the associated risk factors. RESULTS: The age-adjusted annual incidence rate of patients treated for VTDR significantly decreased from 10.05 per 1000 T2DM patients in 2006 to 6.11 in 2017 (β = - 0.3192, P < 0.0001). The sex-adjusted annual incidence rate also significantly decreased in both men (β = - 0.2861, P < 0.0001) and women (β = - 0.3666, P < 0.0001). Cox hazard analysis showed that factors such as insulin use, young age, chronic kidney disease and male sex were significantly associated with increased rate of treatments for VTDR. In addition, the risk was lower for rural than for metropolitan residents. CONCLUSIONS: Despite the increase in the number of T2DM patients in South Korea, the incidence rate of patients treated for VTDR decreases with early diagnosis and appropriate treatment. Therefore, it is important to detect and manage high-risk groups early to prevent visual impairment due to VTDR.
PURPOSE: To determine the age- and sex-specific annual incidence rates of patients treated for VTDR and the factors associated with increased treatment rates in patients with type 2 diabetes mellitus (T2DM) in South Korea. METHODS: This was a nationwide, retrospective, 12-year, population-based study. Patients aged over 30 years who were diagnosed with T2DM between 2006 and 2017 were included in this study. We evaluated the national health claims data acquired from the Korean National Health Insurance Service database. Main outcome measures were the annual incidence rates of patients treated for VTDR and the associated risk factors. RESULTS: The age-adjusted annual incidence rate of patients treated for VTDR significantly decreased from 10.05 per 1000 T2DM patients in 2006 to 6.11 in 2017 (β = - 0.3192, P < 0.0001). The sex-adjusted annual incidence rate also significantly decreased in both men (β = - 0.2861, P < 0.0001) and women (β = - 0.3666, P < 0.0001). Cox hazard analysis showed that factors such as insulin use, young age, chronic kidney disease and male sex were significantly associated with increased rate of treatments for VTDR. In addition, the risk was lower for rural than for metropolitan residents. CONCLUSIONS: Despite the increase in the number of T2DM patients in South Korea, the incidence rate of patients treated for VTDR decreases with early diagnosis and appropriate treatment. Therefore, it is important to detect and manage high-risk groups early to prevent visual impairment due to VTDR.
Authors: Heike U Krämer; Gernot Rüter; Ben Schöttker; Dietrich Rothenbacher; Thomas Rosemann; Joachim Szecsenyi; Hermann Brenner; Elke Raum Journal: Am J Manag Care Date: 2012-07 Impact factor: 2.229
Authors: R N Bailey; R W Indian; X Zhang; L S Geiss; M R Duenas; J B Saaddine Journal: MMWR Morb Mortal Wkly Rep Date: 2006-12-15 Impact factor: 17.586
Authors: Sannapaneni Krishnaiah; Taraprasad Das; Praveen K Nirmalan; Bindiganavale R Shamanna; Rishita Nutheti; Gullapalli N Rao; Ravi Thomas Journal: Clin Ophthalmol Date: 2007-12